转移性结直肠癌患者在伊立替康治疗期间使用阿托品预处理后未出现早期腹泻。 - Suppr

The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients.

作者信息

Yumuk P F, Aydin S Z, Dane F, Gumus M, Ekenel M, Aliustaoglu M, Karamanoglu A, Sengoz M, Turhal S N

出版信息

Int J Colorectal Dis. 2004 Nov;19(6):609-10. doi: 10.1007/s00384-004-0613-5. Epub 2004 Aug 4.

DOI:10.1007/s00384-004-0613-5

PMID:15293062

Abstract

摘要

相似文献

The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients.

Int J Colorectal Dis. 2004 Nov;19(6):609-10. doi: 10.1007/s00384-004-0613-5. Epub 2004 Aug 4.

Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups.

Br J Cancer. 2000 Aug;83(4):431-7. doi: 10.1054/bjoc.2000.1303.

Relationship of serum bilirubin to toxicity in patients with metastatic colorectal cancer treated with single-agent high-dose irinotecan.

J Clin Oncol. 2005 Jan 20;23(3):650; author reply 650-1. doi: 10.1200/JCO.2005.05.163.

Moving beyond fluorouracil for colorectal cancer.

N Engl J Med. 2000 Sep 28;343(13):963-4. doi: 10.1056/NEJM200009283431309.

[Irinotecan in the second-line therapy of metastatic colorectal carcinoma].

Z Gastroenterol. 1999 Jun;37(6):575-7.

A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma.

Cancer. 1999 Feb 15;85(4):786-95.

[Application and recent research progress of irinotecan in treatment of advanced colorectal cancer].

Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):718-9.

A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer.

Cancer Chemother Pharmacol. 2003 Oct;52(4):339-45. doi: 10.1007/s00280-003-0601-4. Epub 2003 Jul 8.

[Relationship between UGT1A and irinotecan-related toxicity].

Zhonghua Zhong Liu Za Zhi. 2013 Apr;35(4):241-3. doi: 10.3760/cma.j.issn.0253-3766.2013.04.001.

Irinotecan for metastatic colorectal cancer.

Med Lett Drugs Ther. 1997 Jan 17;39(992):8.

引用本文的文献

Efficacy of Hangeshashinto in the Prevention of Chemotherapy-Induced Diarrhea: A Systematic Review and Meta-Analysis.

Cureus. 2023 Dec 12;15(12):e50377. doi: 10.7759/cureus.50377. eCollection 2023 Dec.

CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan.

Cell Cycle. 2023 Jul;22(13):1563-1582. doi: 10.1080/15384101.2023.2217003. Epub 2023 Jun 2.

Muscarinic Receptors Associated with Cancer.

Cancers (Basel). 2022 May 7;14(9):2322. doi: 10.3390/cancers14092322.

Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome.

Cancer Chemother Pharmacol. 2019 Mar;83(3):393-398. doi: 10.1007/s00280-018-3736-z. Epub 2018 Dec 18.

Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.

Clin Pharmacokinet. 2018 Oct;57(10):1229-1254. doi: 10.1007/s40262-018-0644-7.

HuangQin Decoction Attenuates CPT-11-Induced Gastrointestinal Toxicity by Regulating Bile Acids Metabolism Homeostasis.

Front Pharmacol. 2017 Mar 30;8:156. doi: 10.3389/fphar.2017.00156. eCollection 2017.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献